首页> 外国专利> TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH AN HETEROAROMATIC GROUP AND A SUBSTITUTED THIOCHROMANYL GROUP IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS

TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH AN HETEROAROMATIC GROUP AND A SUBSTITUTED THIOCHROMANYL GROUP IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS

机译:联合其他抗肿瘤剂治疗的乙酰丙氨酸被杂多酸基团和取代的硫代铬基团取代的肿瘤

摘要

Compounds of Formula 1 Formula 1 where the symbols have the meaning described in the specification, and particularly the compound of Formula 3 Formula 3 (tazarotene) exhibit synergistic anti-proliferative effect with human recombinant interferon in the treatment of solid tumors and leukemia, particularly breast cancer and acute myeloid leukemia.
机译:其中符号具有说明书中所述含义的式1式1化合物,特别是式3式3化合物(他扎罗汀)与人重组干扰素在实体瘤和白血病,尤其是乳腺癌的治疗中具有协同抗增殖作用癌症和急性髓细胞性白血病。

著录项

  • 公开/公告号EP1313509B1

    专利类型

  • 公开/公告日2006-04-26

    原文格式PDF

  • 申请/专利权人 ALLERGAN INC.;

    申请/专利号EP20010964077

  • 申请日2001-08-15

  • 分类号A61K45/06;A61P35;A61K31/4436;A61K38/21;

  • 国家 EP

  • 入库时间 2022-08-21 21:31:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号